Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure (from BIOSTAT-CHF)

Trimethylamine N -oxide: A harmful, protective or diagnostic marker in lifestyle diseases?

(2018) Artur Nowiński et al.   NUTRITION

Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure

(2017) Adriaan A. Voors et al.   EUROPEAN JOURNAL OF HEART FAILURE

Trimethylamine-N-oxide and Heart Failure With Reduced Versus Preserved Ejection Fraction

(2017) Katharina Schuett et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012

(2016) Tonje Thorvaldsen et al.   EUROPEAN JOURNAL OF HEART FAILURE

A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF

(2016) Adriaan A. Voors et al.   EUROPEAN JOURNAL OF HEART FAILURE

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

TrimethylamineN-oxide and prognosis in acute heart failure

(2016) Toru Suzuki et al.   HEART

Pathogenic Gut Flora in Patients With Chronic Heart Failure

(2016) Evasio Pasini et al.   JACC-Heart Failure

High mass accuracy assay for trimethylamine N-oxide using stable-isotope dilution with liquid chromatography coupled to orthogonal acceleration time of flight mass spectrometry with multiple reaction monitoring

(2015) Liam M. Heaney et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis

(2015) Zeneng Wang et al.   CELL

Intestinal Microbiota-Dependent Phosphatidylcholine Metabolites, Diastolic Dysfunction, and Adverse Clinical Outcomes in Chronic Systolic Heart Failure

(2015) W.H. Wilson Tang et al.   JOURNAL OF CARDIAC FAILURE

Pathophysiology and clinical evaluation of acute heart failure

(2015) Robert J. Mentz et al.   Nature Reviews Cardiology

Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine- N -Oxide

(2015) Kymberleigh A. Romano et al.   mBio

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis

(2014) R. W. Troughton et al.   EUROPEAN HEART JOURNAL

Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure

(2014) M. Trøseid et al.   JOURNAL OF INTERNAL MEDICINE

Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure

(2014) W.H. Wilson Tang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis

(2013) Robert A Koeth et al.   NATURE MEDICINE

Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)

(2008) Serge Masson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY